There is currently a class action lawsuit against AstraZeneca, which alleges that their COVID-19 vaccination has caused dozens of deaths and serious injuries. Recently, AstraZeneca admitted in court documents that their vaccine can produce a rare adverse effect.

The Telegraph

There is currently a class action lawsuit against AstraZeneca, which alleges that their COVID-19 vaccination has caused dozens of deaths and serious injuries. Recently, the pharmaceutical giant admitted in court documents that their vaccine can produce a rare adverse effect.

Pharmaceutical company AstraZeneca has admitted, in court documents filed as part of a class-action suit against it, that their COVID-19 vaccine can produce a rare adverse effect.

WION

Legal documents presented to the UK High Court that its COVID-19 vaccine "can, in very rare cases, cause TTS," or Thrombosis with Thrombocytopenia Syndrome, which causes blood clots and low platelet counts. The admission might lead to a multi-million-pound settlement.

In response to the suit accusing its jab of causing dozens of death and serious injuries, AstraZeneca in legal documents presented to the UK High Court wrote the jab can "in very rare cases" cause Thrombosis with Thrombocytopenia Syndrome (TTS), which causes blood clots and low platelet counts.

Yahoo News

There are 51 High Court claims filed by victims and bereaved relatives claiming up to £100 million in damages. Legal experts say the AstraZeneca-Oxford vaccine is “defective” and “vastly overstated.” AstraZeneca disputes these charges.

Fifty-one High Court claims have been filed by victims and bereaved relatives who are seeking up to £100 million in damages over what they say is a "defective" and "vastly overstated" vaccine. AstraZeneca disputes these charges.

After the COVID-19 vaccine was released in March 2021, experts instantly linked immunization to vaccine-induced thrombocytopenia and thrombosis (VITT) Plaintiffs' attorneys say AstraZeneca denies VITT as a TTS subtype. The UK government has indemnified AstraZeneca but has not yet intervened.

Daily Mail

After the COVID-19 vaccine was released in March 2021, experts instantly linked immunization to vaccine-induced thrombocytopenia and thrombosis (VITT) Plaintiffs' attorneys say AstraZeneca denies VITT as a TTS subtype. In case of a settlement, UK taxpayers will foot the bill, as the UK government has indemnified AstraZeneca.

Health officials linked immunization to vaccine-induced thrombocytopenia and thrombosis (VITT) shortly after the jabs were released in March 2021, but AstraZeneca previously denied VITT as a TTS subtype.

At least 81 UK deaths are thought to have been caused by the adverse reaction that caused clotting in persons with low blood platelets, according to MHRA data. The MHRA reported that over 20% of those with the illness died.

At least 81 UK deaths are thought to have been caused by the adverse reaction that caused clotting in persons with low blood platelets, according to data from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA reported that over 20% of those with the illness died.

Data from the Medicines and Healthcare products Regulatory Agency (MHRA) reported 81 UK deaths that were thought to have been caused by an adverse reaction to the vaccine, which caused clotting in persons with low blood platelets. The MHRA reported more than 20% of those died.

In the first year of the pandemic, independent research found that AstraZeneca's vaccine prevented over 6M deaths. When the vaccine was first introduced, former Prime Minister Boris Jonson hailed the vaccine as a "triumph for British science." However, the UK is not currently using the vaccine.

In the first year of the pandemic, independent research found that AstraZeneca's vaccine prevented over 6M deaths. However, the UK is not currently using the AstraZeneca vaccine.

Daily Mail #

People have died, and others have become severely disabled and have enormous medical expenditures. Others are seeking justice for loved ones lost or lives upended due to vaccine injuries after taking AstraZeneca's COVID-19 vaccine. It's important to note that these people took the vaccine to avoid dying from the pandemic, not to suffer from its side effects.

AstraZeneca admits for first time its Covid vaccine CAN cause rare side effect in tense legal fight with victims of 'defective' jab

The AstraZeneca COVID-19 vaccine is safe and has played a crucial role in saving millions of lives worldwide. Patient safety is our priority, and we are proud to say that all of our medicines, including vaccines, have successfully met the rigorous safety standards set by regulatory authorities. The overwhelming evidence supports the idea that the benefits of the AstraZeneca-Oxford vaccine far outweigh the extremely rare potential of side effects, such as the possibility of triggering TTS.

AstraZeneca admits for first time in court documents its Covid vaccine can cause rare side effect

There is a 90% chance that before 2032, an intranasal SARS-CoV-2 vaccine candidate will be approved by the USA, UK, EU, or Canada, according to the Metaculus prediction community.

Metaculus

Metaculus #

Intranasal SARS-CoV-2 Vaccine Authorized

BSR Agency / Contributor / Getty Images News via Getty Images***PLEASE REPLACE***

COVID-19

Medicine & healthcare

Vaccination

Diseases & conditions

United Kingdom

While this is the first time AstraZeneca has admitted to the connection between its vaccine and TTS, the company has always acknowledged this could be a very rare side effect of the jab. However, there could be other contributing factors to patients developing TTS. Aside from the few instances where recipients may have suffered this rare side effect, the vaccine has saved millions wherever it was distributed.

New York Post

AstraZeneca cops to rare, deadly side effect of COVID jab as lawsuits mount

As the claimants in this case can attest, AstraZeneca downplayed the risks of this vaccine while exaggerating its effectiveness. Otherwise healthy people have faced the consequences of these side effects and the pharmaceutical company must compensate the ones who survived their unnecessary medical crises.

Sky News

Dad who suffered brain injury days after getting COVID vaccine sues AstraZeneca

There's a 90% chance that before Jan. 1, 2032, an intranasal SARS-CoV-2 vaccine candidate will be approved by the USA, UK, EU, or Canada, according to the Metaculus prediction community.

Ulet Ifansasti/Stringer/Getty Images News via Getty Images

Videos

Apps

AstraZeneca admits for first time in court documents its Covid vaccine can cause rare side effect

AstraZeneca admits for first time in court documents its Covid vaccine can cause rare side effect

The Facts

The Spin

Metaculus Prediction

Sign up to our daily newsletter